Case Report: Management of recurrent UTI with tigecycline in a kidney transplant recipient

This case report describes a 37-year-old man who underwent renal transplantation and subsequently developed complicated recurrent urinary tract infections (UTIs) caused by multidrug-resistant (MDR) <i>Klebsiella pneumoniae</i>. Despite initial treatment with fosfomycin and meropenem, the patient experienced persistent UTIs, leading to multiple hospitalizations. The management of these recurrent infections eventually required the use of tigecycline. Although tigecycline is not typically considered a urinary antibiotic owing to its limited urinary excretion, it was successfully employed in this case to manage the recurrent infections. The patient was treated with tigecycline for several episodes of UTI, which provided a crucial therapeutic option in the context of antibiotic resistance. This case underscores the challenges of managing recurrent MDR UTIs in immunocompromised patients and highlights tigecycline as an effective treatment strategy when standard therapies fail.

Authors

Institutions

Publication Details

Journal
Frontiers in Transplantation
Published
2025-02-18
DOI
https://doi.org/10.3389/frtra.2024.1496702
Primary Topic
Urinary Tract Infections Management
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Case Report: Management of recurrent UTI with tigecycline in a kidney transplant recipient

Ramakota Reddy, Manjunath S Shetty, Gautam Kalyatanda, Asha Srinivasan et al.
Frontiers in Transplantation
Urinary Tract Infections Management
article

Case Report: Management of recurrent UTI with tigecycline in a kidney transplant recipient

Ramakota Reddy, Manjunath S Shetty, Gautam Kalyatanda, Asha Srinivasan, Shruthi Shree S. C., Yogeesh D. Maheshwarappa, Supreeta R. Shettar, Mahadevaiah Neelambike Sumana, V. P
article en

Abstract

This case report describes a 37-year-old man who underwent renal transplantation and subsequently developed complicated recurrent urinary tract infections (UTIs) caused by multidrug-resistant (MDR) <i>Klebsiella pneumoniae</i>. Despite initial treatment with fosfomycin and meropenem, the patient experienced persistent UTIs, leading to multiple hospitalizations. The management of these recurrent infections eventually required the use of tigecycline. Although tigecycline is not typically considered a urinary antibiotic owing to its limited urinary excretion, it was successfully employed in this case to manage the recurrent infections. The patient was treated with tigecycline for several episodes of UTI, which provided a crucial therapeutic option in the context of antibiotic resistance. This case underscores the challenges of managing recurrent MDR UTIs in immunocompromised patients and highlights tigecycline as an effective treatment strategy when standard therapies fail.

Frontiers in TransplantationVol. 3
JSS Academy of Higher Education and Research (IN), University of Florida (US), JSS Medical College and Hospital (IN)
JSS Academy of Higher Education and Research
Openalex Percentile: Top 95%
Urinary Tract Infections Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Case Report: Management of recurrent UTI with tigecycline in a kidney transplant recipient — Ramakota Reddy, Manjunath S Shetty, et al. · Frontiers in Transplantation (2025) | TGRS Research Map | TGRS